Attached files

file filename
10-K - FORM 10-K - Midatech Pharma US Inc.d10k.htm
EX-21 - SUBSIDIARIES OF DARA BIOSCIENCES, INC. - Midatech Pharma US Inc.dex21.htm
EX-23 - CONSENT OF ERNST & YOUNG LLP - Midatech Pharma US Inc.dex23.htm
EX-31.2 - SECTION 302 CFO CERTIFICATION - Midatech Pharma US Inc.dex312.htm
EX-31.1 - SECTION 302 CEO CERTIFICATION - Midatech Pharma US Inc.dex311.htm
EX-10.25 - STOCK PURCHASE AGREEMENT - Midatech Pharma US Inc.dex1025.htm

Exhibit 32

CERTIFICATIONS OF

CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Richard A. Franco, Sr., certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Annual Report of DARA BioSciences, Inc. on Form 10-K for the year ended December 31, 2009 fully complies with the requirements of Section 13(a) or 15(d) of the Exchange Act and that information contained in such Annual Report of DARA BioSciences, Inc. on Form 10-K fairly presents in all material respects the financial condition and results of operations of DARA BioSciences, Inc.

 

By:  

/s/ Richard A. Franco, Sr.

Name:   Richard A. Franco, Sr.
Title:   President and Chief Executive Officer
Date:   March 9, 2010

I, Ann A. Rosar, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Annual Report of DARA BioSciences, Inc. on Form 10-K for the year ended December 31, 2009 fully complies with the requirements of Section 13(a) or 15(d) of the Exchange Act and that information contained in such Annual Report of DARA BioSciences, Inc. on Form 10-K fairly presents in all material respects the financial condition and results of operations of DARA BioSciences, Inc.

 

By:  

/s/ Ann A. Rosar

Name:   Ann A. Rosar
Title:   Chief Accounting Officer
Date:   March 9, 2010